- Home
- AP vs ZURA Comparison
AP vs ZURA Comparison
Compare AP & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AP
- ZURA
- Stock Information
- Founded
- AP 1929
- ZURA 2022
- Country
- AP United States
- ZURA United States
- Employees
- AP N/A
- ZURA N/A
- Industry
- AP Fluid Controls
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AP Industrials
- ZURA Health Care
- Exchange
- AP Nasdaq
- ZURA Nasdaq
- Market Cap
- AP 54.7M
- ZURA 61.9M
- IPO Year
- AP N/A
- ZURA N/A
- Fundamental
- Price
- AP $3.70
- ZURA $1.26
- Analyst Decision
- AP
- ZURA Buy
- Analyst Count
- AP 0
- ZURA 7
- Target Price
- AP N/A
- ZURA $14.33
- AVG Volume (30 Days)
- AP 103.7K
- ZURA 611.5K
- Earning Date
- AP 05-12-2025
- ZURA 05-08-2025
- Dividend Yield
- AP N/A
- ZURA N/A
- EPS Growth
- AP N/A
- ZURA N/A
- EPS
- AP 0.22
- ZURA N/A
- Revenue
- AP $412,355,000.00
- ZURA N/A
- Revenue This Year
- AP N/A
- ZURA N/A
- Revenue Next Year
- AP N/A
- ZURA N/A
- P/E Ratio
- AP $17.18
- ZURA N/A
- Revenue Growth
- AP N/A
- ZURA N/A
- 52 Week Low
- AP $0.74
- ZURA $0.97
- 52 Week High
- AP $3.99
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- AP 73.01
- ZURA 58.93
- Support Level
- AP $3.42
- ZURA $0.98
- Resistance Level
- AP $3.99
- ZURA $1.06
- Average True Range (ATR)
- AP 0.30
- ZURA 0.08
- MACD
- AP 0.06
- ZURA 0.03
- Stochastic Oscillator
- AP 77.52
- ZURA 87.50
About AP Ampco-Pittsburgh Corporation
Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.